TapewireFind a company

person · Reporting owner

Lee Chan Henry

Disclosed activity across 1 company

Tapewire entity
23729
SEC CIK
0001980648

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BeOne Medicines Ltd.ONC · Entity 2168SVP, General CounselSeptember 30, 2026October 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BeOne Medicines Ltd.

Report date September 30, 2026 · Filed October 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
American Depositary SharesSEC Table I · non-derivativeDirect0 Reported balance After 2026-09-30 transaction · row 2 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 2 · 2026-09-30 · Sale · Disposed 1,115 · Balance 0

F2: Each American Depositary Share represents 13 Ordinary Shares.

F3: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.

Ordinary SharesSEC Table I · non-derivativeDirect311,324 Reported balance Holding disclosure · report date 2026-09-30 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 311,324

F1: Includes 507 ordinary shares acquired pursuant to the Company's 2018 Employee Share Purchase Plan, as amended from time to time.

Filing footnotes · ownership attribution and instrument terms

F1: Includes 507 ordinary shares acquired pursuant to the Company's 2018 Employee Share Purchase Plan, as amended from time to time.

F2: Each American Depositary Share represents 13 Ordinary Shares.

F3: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 06, 2026 Filed Mar 11, 2026 00:13 UTC BeOne Medicines Ltd. ONC · Entity 2168 GrantOrdinary Shares 29,874 $0.00 $0.00
Disclosure

SEC source: 0001980648-26-000005 · wk-form4_1773188022.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 318,370

F2 · shares: Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2028, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
March 06, 2026 Filed Mar 11, 2026 00:13 UTC BeOne Medicines Ltd. ONC · Entity 2168 GrantOrdinary Shares 65,390 $0.00 $0.00
Disclosure

SEC source: 0001980648-26-000005 · wk-form4_1773188022.xml · nonDerivative · entry 1

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 288,496

F1 · shares: Represents the total number of ordinary shares underlying the performance share units earned by Reporting Person. The earned performance share units will vest in 2027, subject to the Reporting Person continuing to provide service to the Company through such vesting date. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
February 04, 2026 Filed Feb 6, 2026 21:57 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 6,448 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · derivative · entry 9

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,670

Underlying: Ordinary Shares · 6,448 shares

Expires 2034-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
February 04, 2026 Filed Feb 6, 2026 21:57 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 8,606 $0.00 Strike: $16.41 $0.00
Disclosure

SEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · derivative · entry 8

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,413

Underlying: Ordinary Shares · 8,606 shares

Expires 2033-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F5 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
February 04, 2026 Filed Feb 6, 2026 21:57 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 6,526 $0.00 Strike: $14.96 $0.00
Disclosure

SEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · derivative · entry 7

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,920

Underlying: Ordinary Shares · 6,526 shares

Expires 2032-08-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
February 04, 2026 Filed Feb 6, 2026 21:57 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 996 $350.00 $348,600.00
Disclosure

SEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · nonDerivative · entry 6

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Read SEC document
February 04, 2026 Filed Feb 6, 2026 21:57 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 664 $348.79 $231,596.56
Disclosure

SEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · nonDerivative · entry 5

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 996

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Read SEC document
February 04, 2026 Filed Feb 6, 2026 21:57 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 496 $159.03 $78,878.88
Disclosure

SEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · nonDerivative · entry 4

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,660

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
February 04, 2026 Filed Feb 6, 2026 21:57 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 662 $213.32 $141,217.84
Disclosure

SEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · nonDerivative · entry 3

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,164

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
February 04, 2026 Filed Feb 6, 2026 21:57 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 502 $194.47 $97,623.94
Disclosure

SEC source: 0001980648-26-000004 · wk-form4_1770415037.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 502

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 22:15 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 2,548 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · derivative · entry 8

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,118

Underlying: Ordinary Shares · 2,548 shares

Expires 2034-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 22:15 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 3,458 $0.00 Strike: $16.41 $0.00
Disclosure

SEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · derivative · entry 7

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 97,019

Underlying: Ordinary Shares · 3,458 shares

Expires 2033-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F5 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 22:15 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 2,626 $0.00 Strike: $14.96 $0.00
Disclosure

SEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · derivative · entry 6

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,446

Underlying: Ordinary Shares · 2,626 shares

Expires 2032-08-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 22:15 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 664 $331.76 $220,288.64
Disclosure

SEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · nonDerivative · entry 5

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 22:15 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 196 $159.03 $31,169.88
Disclosure

SEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · nonDerivative · entry 4

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 664

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 22:15 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 266 $213.32 $56,743.12
Disclosure

SEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · nonDerivative · entry 3

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 468

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 22:15 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 202 $194.47 $39,282.94
Disclosure

SEC source: 0001980648-26-000002 · wk-form4_1767996952.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 202

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
December 11, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 1,274 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · derivative · entry 15

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,666

Underlying: Ordinary Shares · 1,274 shares

Expires 2034-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
December 11, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 1,729 $0.00 Strike: $16.41 $0.00
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · derivative · entry 14

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100,477

Underlying: Ordinary Shares · 1,729 shares

Expires 2033-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F5 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
December 11, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 1,313 $0.00 Strike: $14.96 $0.00
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · derivative · entry 13

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,072

Underlying: Ordinary Shares · 1,313 shares

Expires 2032-08-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
December 11, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 332 $325.00 $107,900.00
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 9

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Read SEC document
December 11, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 98 $159.03 $15,584.94
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 8

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 332

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
December 11, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 133 $213.32 $28,371.56
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 7

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 234

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
December 11, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 101 $194.47 $19,641.47
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 6

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 101

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 1,274 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · derivative · entry 12

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,940

Underlying: Ordinary Shares · 1,274 shares

Expires 2034-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 1,729 $0.00 Strike: $16.41 $0.00
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · derivative · entry 11

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,206

Underlying: Ordinary Shares · 1,729 shares

Expires 2033-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F5 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 1,313 $0.00 Strike: $14.96 $0.00
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · derivative · entry 10

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,385

Underlying: Ordinary Shares · 1,313 shares

Expires 2032-08-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 332 $318.28 $105,668.96
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 5

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 98 $159.03 $15,584.94
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 4

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 332

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 133 $213.32 $28,371.56
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 3

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 234

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
December 10, 2025 Filed Dec 12, 2025 21:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 101 $194.47 $19,641.47
Disclosure

SEC source: 0001980648-25-000006 · wk-form4_1765576578.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 101

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:28 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 3,848 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · derivative · entry 9

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,214

Underlying: Ordinary Shares · 3,848 shares

Expires 2034-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:28 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 5,174 $0.00 Strike: $16.41 $0.00
Disclosure

SEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · derivative · entry 8

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 103,935

Underlying: Ordinary Shares · 5,174 shares

Expires 2033-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F5 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:28 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 3,926 $0.00 Strike: $14.96 $0.00
Disclosure

SEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · derivative · entry 7

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,698

Underlying: Ordinary Shares · 3,926 shares

Expires 2032-08-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F4 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:28 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 332 $350.00 $116,200.00
Disclosure

SEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · nonDerivative · entry 6

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:28 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 664 $348.75 $231,570.00
Disclosure

SEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · nonDerivative · entry 5

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 332

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:28 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 296 $159.03 $47,072.88
Disclosure

SEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · nonDerivative · entry 4

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 996

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:28 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 398 $213.32 $84,901.36
Disclosure

SEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · nonDerivative · entry 3

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
November 12, 2025 Filed Nov 14, 2025 22:28 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 302 $194.47 $58,729.94
Disclosure

SEC source: 0001980648-25-000004 · wk-form4_1763159300.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 302

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 20:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 3,848 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · derivative · entry 11

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,062

Underlying: Ordinary Shares · 3,848 shares

Expires 2034-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F8 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 20:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 116,493 $0.00 Strike: $16.41 $0.00
Disclosure

SEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · derivative · entry 10

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,109

Underlying: Ordinary Shares · 116,493 shares

Expires 2033-06-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F7 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 20:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 3,926 $0.00 Strike: $14.96 $0.00
Disclosure

SEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · derivative · entry 9

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,624

Underlying: Ordinary Shares · 3,926 shares

Expires 2032-08-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 20:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 4,162 $351.12 $1,461,374.76
Disclosure

SEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 8

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.00 to $351.53, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 20:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 4,733 $350.22 $1,657,580.37
Disclosure

SEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 7

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,162

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.98, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 20:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 664 $347.82 $230,952.48
Disclosure

SEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 6

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,895

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 20:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 296 $159.03 $47,072.88
Disclosure

SEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 5

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,559

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 20:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 8,961 $213.32 $1,911,560.52
Disclosure

SEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 4

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,263

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 20:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionAmerican Depositary Shares 302 $194.47 $58,729.94
Disclosure

SEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 3

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 302

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

Read SEC document
October 08, 2025 Filed Oct 10, 2025 20:56 UTC BeOne Medicines Ltd. ONC · Entity 2168 SaleAmerican Depositary Shares 1,112 $350.00 $389,200.00
Disclosure

SEC source: 0001980648-25-000003 · wk-form4_1760129810.xml · nonDerivative · entry 2

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · security: Each American Depositary Share represents 13 Ordinary Shares.

F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 20:38 UTC BeOne Medicines Ltd. ONC · Entity 2168 Exercise / conversionShare Option (Right to Buy) · Derivative 3,848 $0.00 Strike: $12.23 $0.00
Disclosure

SEC source: 0001651308-25-000145 · wk-form4_1757709511.xml · derivative · entry 12

Lee Chan Henry · CIK 0001980648 · SVP, General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130,910

Underlying: Ordinary Shares · 3,848 shares

Expires 2034-06-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F8 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.